Skip to main content

Table 5 Estimated costs to the payer for the proposed strategic health purchasing approach (millions of rupiah; U.S. dollarsa)

From: Estimating the budget impact of a Tuberculosis strategic purchasing pilot study in Medan, Indonesia (2018–2019)

Payer

Scenario

Costs of TB diagnostics

Costs of TB treatment

Costs of TB preventive treatment

Total cost

NHI

Current

6,130

($431,394)

4,281

($301,251)

-

10,412

($732,646)

Proposed

3,172

($223,242)

4,843

($340,796)

-

8,016

($564,039)

Relative difference

-48%

13%

 

-23%

Central and local government

Current

1,070

($75,313)

1,780

($125,279)

96

($6,769.20)

2,947

($207,361)

Proposed

10,758

($756,968)

2,993

($210,602)

158 ($11,122.17)

13,909

($978,692)

Relative difference

905%

68%

64%

372%

Global Fund

Current

112

($7,914)

-

-

112

($7,914)

Proposed

1,988

($139,944)

-

-

1,988

($139,944)

Relative difference

1668%

  

1668%

Out-of-pocket

Current

1,444

($101,622)

45

($3,174)

-

1,489

($104,795)

Proposed

0

0

0

0

Relative difference

-100%

-100%

 

-100%

  1. aUS$1 = 14,212 rupiah (Bank Indonesia, June 28, 2019)